The one record cannabis does not show up in
Here's the honest logic for a Valrico patient. The certification storefront model spread east out of Brandon, and the local options mostly share one design: a short visit, a flat rate, a signature. What none of them tend to mention is a structural fact about this program that has real clinical consequences later.
Every prescription you have ever filled leaves a trace in a pharmacy system. That trace is what powers the automatic interaction warning a pharmacist sees, and it is a large part of why medication safety works as well as it does. Medical cannabis does not work that way. It is not prescribed, it is not dispensed by a pharmacy, and it does not appear in your pharmacy profile. The state registry is a Department of Health record, not a clinical system that your surgeon, your cardiologist, or an emergency physician queries in the ordinary course of care.
The practical consequence is that a cannabinoid you use daily is invisible to every automated safety check in medicine unless a human being enters it. That human being is usually you. It is the single most useful piece of information on this page, and it is worth more than any amount of comparison between one certification office and another.
The renewal side of the program is genuinely low-friction, for what it is worth. A telehealth renewal visit needs a device with a camera, an internet connection that holds up, and your physical presence in Florida during the call. That is the whole equipment list, and our coordinators handle the setup walkthrough ahead of time.
The legal skeleton: statute, registry, state card
Three structures hold up the entire Florida program, and knowing them ahead of time makes the process far less mysterious. First is Section 381.986 of the Florida Statutes, which defines who may recommend cannabis (physicians registered with the Office of Medical Marijuana Use as qualifying physicians), for whom (adults with the specific conditions the statute lists), and how. Second is the Compassionate Use Registry, where the physician's recommendation is entered; nothing is prescribed, because federal law still classifies cannabis as Schedule I and prescriptions for it don't legally exist. Third is the state ID card, which you apply for through the OMMU after your registry entry, paying the state's fee directly to the state. Issuance typically takes a few weeks.
Only after all three steps can you walk into a licensed Medical Marijuana Treatment Center and purchase anything. Notice where the physician's job stops: at the evaluation and the registry entry. We don't sell products, we don't steer you to a particular dispensary, and any clinic that blends those roles together has left the structure the statute actually describes. The card itself stays valid for the period the state sets, and the physician relationship continues underneath it, since Florida requires periodic re-evaluation to keep the registry recommendation alive. Think of the card as the output and the ongoing evaluations as the engine. Let the engine lapse and the output stops with it.
Qualifying conditions Florida actually recognizes
The current statutory list: cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder, amyotrophic lateral sclerosis, Crohn's disease, Parkinson's disease, multiple sclerosis, conditions of the same kind or class as those listed, terminal conditions diagnosed by a second physician, and chronic nonmalignant pain that is caused by or originates from a qualifying condition. Legislatures amend lists like this one, so treat any webpage, ours included, as a snapshot; eligibility gets confirmed against the statute in force on the day of your evaluation.
Two entries generate most of the confusion we see. Chronic pain is on the list only conditionally: the statute wants a documented causal link between your pain and a qualifying condition, and pain standing alone doesn't clear that bar. PTSD requires an actual documented diagnosis rather than self-identified trauma symptoms, and if you've never been formally evaluated, our psychiatric team can do that properly before any cannabis conversation happens. The "same kind or class" language, meanwhile, is a clinical judgment the physician defends, not a loophole a patient invokes.
What to gather before the appointment
Records decide these evaluations more than anything said in the room. Useful items include specialist notes naming the diagnosis, imaging reports, operative reports if relevant, a list of medication trials with outcomes, and anything documenting how long the condition has been treated. Bring a current medication list too, supplements included, because interaction screening is part of the visit. If your records live at another practice, request them a week or two ahead; getting copies from another office can take a few weeks, and waiting on paperwork is the most common reason a certification stalls.
What Dr. Saylor covers in the exam room
Set aside 30 to 45 minutes. Dr. Saylor is a board-certified osteopathic family medicine physician with 17 years of clinical experience and serves as Ascend's Chief Medical Officer, and the appointment runs the way his chronic disease visits run: history first, then the medication list, then the documentation for the qualifying condition, then a frank conversation about what cannabis evidence looks like for your particular situation and what the risks and interactions are. You'll also walk through the OMMU card process and the renewal rhythm so nothing after the visit surprises you.
Cannabis is never presented as the opening move. In most cases it makes sense, if it makes sense at all, alongside or after conventional treatment, and part of the evaluation is checking whether the conventional side has actually been tried. When everything lines up, the registry entry can often happen the same day. When it doesn't, we say so directly and map out what would need to change, whether that's a formal psychiatric evaluation, a proper pain workup, or a different treatment entirely. A practice willing to say no is the thing the fifteen-minute model structurally can't offer.
Coordination continues after the visit, because most qualifying conditions already have other clinicians attached. Cancer symptom relief gets discussed with oncology. Crohn's management stays anchored in gastroenterology, spasticity from multiple sclerosis and the symptom burden of Parkinson's stay anchored in neurology, and pain patients keep their non-cannabis pain management moving in parallel. When a cannabinoid changes how another condition gets medicated, we make sure the prescriber on the other end knows about it. That's ordinary medicine, and it's exactly the layer the certification-only model deletes.
What the research says about cannabis and pain
Strip away the marketing and the evidence base is narrower than the billboards suggest. The 2017 National Academies consensus review, still the field's most careful summary, identified substantial evidence for cannabis or cannabinoids in adult chronic pain and in chemotherapy-induced nausea and vomiting, plus moderate evidence for spasticity in multiple sclerosis. For most other advertised uses it found the evidence limited or insufficient, with long-term outcome data thin everywhere. PTSD research, despite PTSD's prominence in certification advertising, remains mixed.
On the regulatory side: cannabis stays Schedule I federally, the FDA has approved it for nothing, and the lone FDA-approved cannabis-derived prescription medicine is purified CBD for certain rare seizure disorders rather than anything a dispensary stocks. We put all of this on the table because informed consent requires it, and because no honest clinic can guarantee approval or benefit. Responses vary person to person, and a physician who claims otherwise is quoting a business model.
Tradeoffs that belong in the decision
Before applying, three legal realities deserve unhurried thought. Behind the wheel: Florida's DUI law covers impairment by any controlled substance, and a medical card provides no defense; operating a vehicle while impaired stays illegal, card or not. Firearms: federal law at 18 U.S.C. § 922(g)(3) bars controlled-substance users from buying or possessing guns, and the federal purchase form asks about marijuana explicitly, ignoring state medical status entirely. Employment: Florida does not force employers to accommodate medical cannabis, so a positive test can still carry consequences at work even with a valid card, and safety-sensitive or federally regulated jobs are the highest-risk cases.
We raise these at the evaluation because they belong in the decision, not because they end it. Plenty of patients weigh the tradeoffs and proceed with clear eyes, which is the whole point. Certification is available to adults 18 and older, and everything on this page is information rather than legal advice.
How the billing works, without a price list
Insurers almost universally sit this category out. Cannabis's federal Schedule I status means plans generally won't reimburse certification services no matter what state law says, so plan on the evaluation being self-pay. Structurally there are two payments on the road to a card, and they go to different places: the clinical visit fee paid to the practice, which our billing team quotes when you call (813) 670-3331, and the OMMU's ID-card application fee paid straight to the state, which never passes through us.
There's one insurance door that sometimes opens. When the condition underneath the certification needs its own medical management, chronic pain or PTSD being the common examples, that management visit can in many cases be billed to insurance separately from the cannabis certification itself. Ask about it when you call; it's the sort of option that only exists when the certifying physician actually practices medicine beyond certifications. If you plan to lean on a health savings or flexible spending account instead, check with your administrator before assuming anything, since many plans exclude cannabis-related expenses on federal-status grounds.
Surgery, anesthesia, and the emergency department
Since nothing enters the record automatically, here is where telling someone actually matters. These are the settings where an unmentioned cannabinoid changes what a clinician would otherwise do.
Surgery and anesthesia come first. Anesthesiology societies now recommend asking every patient about cannabis before an operation, because regular use appears to change how patients respond to anesthetic agents, and because recent use carries its own risks. Reported effects include needing more induction medication, greater airway irritability in patients who smoke, and higher postoperative pain and analgesic requirements. Some guidance recommends postponing elective surgery when use has been very recent. Your anesthesiologist can plan around all of that easily and can plan around none of it if the question is answered with a no.
Emergency care is second. Cannabis raises heart rate, can affect blood pressure on standing, and can produce anxiety, confusion, or altered thinking that an emergency physician has to distinguish from a dozen more serious causes. There is also a well-described syndrome of cyclic vomiting with abdominal pain in long-term users that is routinely worked up as something else for months, sometimes years, before anyone connects it. Saying it out loud shortens that considerably.
Pregnancy and breastfeeding are third, and the guidance from the major obstetric bodies is not ambiguous: cannabis is not recommended, and the honest position is that the safety data does not support treating it as low risk. If you are pregnant, planning to be, or breastfeeding, that belongs in the conversation well before a registry entry exists.
Fourth is anyone managing a controlled substance for you. If a pain specialist or a psychiatrist is prescribing, they generally have an agreement and a monitoring process that assumes they know everything you are taking. Finding out from a test result rather than from you damages a relationship that is often more important than the certification itself.
The mechanics are ordinary. With your written authorization we will send a note to the physicians you name, and we encourage it. Where you would rather tell them yourself, tell them. Keep the card and a current list of what you actually use on your person, because the moment this information matters most is usually the moment you are least able to supply it.
The in-person visit takes place at our Tampa-Carrollwood office, 3971 Moran Road, Suite 101, Tampa, FL 33618, because a first certification cannot lawfully be made by video anywhere in Florida. Florida's renewal interval is currently 210 days, and those follow-up evaluations can often be done by telehealth provided you're physically in Florida during the call. We work with patients across eastern Hillsborough, including Valrico's 33594 and 33596 ZIP codes plus the Brandon, Lithia and FishHawk, Dover, and Plant City areas surrounding it. Once your OMMU card arrives, every licensed Medical Marijuana Treatment Center in Florida is open to you, wherever you prefer to fill. Getting started is a phone call to (813) 670-3331 or an online booking, and if you're unsure whether your condition and records will qualify, say so up front; the scheduling conversation can flag missing documentation before the appointment instead of during it.
The single sentence that decides most pain certifications
Read the statute closely and one clause does most of the work: chronic nonmalignant pain caused by or originating from a qualifying medical condition. Almost every difficult certification conversation in this practice turns on that phrase, and almost every piece of misleading advertising in this category obscures it.
The distinction is between pain as a symptom and pain as a qualifying condition. A patient with fifteen years of back pain and no diagnosis has a real problem and, as the record currently stands, not necessarily a qualifying one. The same patient with a documented underlying condition that the pain originates from is in an entirely different position under the law, without anything about their experience having changed.
That is why so much of a pain-based evaluation is spent on records rather than on symptoms. Not because the symptoms are in doubt, but because the statute asks a question about causation that only the chart can answer.
Why this is good medicine and not just paperwork
It would be easy to treat the documentation requirement as bureaucratic friction between a patient and something they want. It is worth arguing the other side, because the requirement is doing something useful: it forces somebody to ask where the pain is coming from.
Undiagnosed chronic pain is not a neutral state. It can be mechanical and treatable, it can be inflammatory, it can occasionally be the presenting sign of something that needs finding quickly. A process that certifies without ever asking the origin question leaves all of that unexamined, and the patient walks out with a card and the same unanswered question they came in with.
So when a Valrico patient arrives with pain that has never been traced, the recommendation to work it up first is not a stall. It is the part of the visit most likely to change something.
Related care across eastern Hillsborough
- Chronic pain evaluation: the workup that establishes an origin
- The medical marijuana program: the full program detail
- Brandon certification: with more on requesting specialist records
- Plant City certification: with more on work and testing programs
- Primary care: where a pain workup usually starts
- Dr. Jason Saylor, DO: the physician performing these evaluations
FAQs about medical marijuana evaluation in Valrico
What are Florida's qualifying conditions?
Florida law lists specific qualifying conditions, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class, terminal conditions, and chronic nonmalignant pain caused by or originating from a qualifying medical condition. The list can change as state law evolves; we confirm eligibility at your evaluation based on current statute.
Where is the Valrico evaluation done?
The initial Compassionate Use Registry evaluation is done in-person per Florida law at our Tampa-Carrollwood office (3971 Moran Road, Suite 101, Tampa, FL 33618). Ascend has no office in Valrico. Follow-up visits can often be done via telehealth.
My pain is not from a condition on the list. Do I still qualify?
Possibly, and this is the provision that causes the most confusion. The statute covers chronic nonmalignant pain caused by or originating from a qualifying medical condition. That is a narrower door than "chronic pain qualifies," which is how it is often advertised. The question is whether your pain traces back to a condition the law recognizes, and answering it is a documentation exercise as much as a clinical one.
What does "caused by or originating from" actually require?
A traceable link in the record between the pain you have and an underlying condition the statute lists. In practice that usually means a diagnosis someone established, supported by whatever objective findings exist, with the pain documented as arising from it. Pain that has never been worked up has no origin in the chart yet, which is a fixable problem but not one that can be fixed during the certification visit itself.
Do I need imaging to document chronic pain?
Not always, and imaging alone is not the deciding factor either. What matters is whether the overall record establishes the underlying condition. For some problems imaging is central; for others the diagnosis rests on examination findings, specialist assessment, and a documented course over time. Bring what you have and we will tell you honestly whether it is enough.
Will you stop my current pain treatment if I am certified?
No. Certification is not a replacement for a pain management plan, and cannabis is not positioned here as an exit from treatment that is working. Where controlled substances are involved the interaction question is real and gets discussed, and where another physician is prescribing we would want that coordination to happen rather than run two plans in parallel without either doctor knowing.
What if my pain has never been formally evaluated?
Then the more valuable appointment is probably a pain workup rather than a certification visit. Long-standing pain that nobody has traced to a cause is a genuine clinical question, and occasionally an urgent one. We would rather find out what is generating it than certify around a blank space in the chart, and our chronic pain evaluation exists for exactly that situation.
What if my diagnosis is not on the statutory list at all?
Florida's statute includes conditions of the same kind or class as those it lists, and that provision is read conservatively here rather than as a wide opening. Some conditions genuinely fall within it and some do not, and the determination is a clinical judgment against current statute made at your evaluation. If yours does not fit, we will say so directly and talk about what else is available for it.
Sources
- Florida Statute § 381.986 (medical use of marijuana); Florida Department of Health rule Chapter 64-4, F.A.C.
- Florida Office of Medical Marijuana Use (OMMU), patient registry and ID card guidance
- National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids.
- FDA: cannabis-derived drug approvals and cannabis regulatory status
- 18 U.S.C. § 922(g)(3)
Medical cannabis is regulated under Florida Statute §381.986 and is not approved by the FDA for the treatment of any condition. The clinical evidence varies substantially by condition. Side effects and drug interactions exist and are discussed during evaluation. Cannabis remains a federally controlled Schedule I substance. This page is informational and does not substitute for a clinical visit. See Fla. Stat. § 381.986 and the Florida Department of Health, Office of Medical Marijuana Use (Chapter 64-4, F.A.C.).